Home › Atopic Dermatitis (Eczema) › South Carolina › Charleston
Atopic Dermatitis (Eczema) clinical trials in Charleston, SC
5 studies for Atopic Dermatitis (Eczema) are looking for participants at sites in and around Charleston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
RecruitingPhase 3
- Medical University of South Carolina - South Carolina Translational Research Nexus Clinic, Charleston
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
RecruitingPhase 2
- Investigational Site, Charleston
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
RecruitingPhase 3
- Medical University of South Carolina /ID# 265113, Charleston
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
RecruitingPhase 3
- Leo Pharma Investigational site, Charleston
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
RecruitingPhase 3
- Medical University of South Carolina /ID# 263655, Charleston
Atopic Dermatitis (Eczema) trials in other cities
- New York City, NY13 studies
- Los Angeles, CA11 studies
- Washington, DC11 studies
- San Antonio, TX10 studies
- San Diego, CA10 studies
- Miami, FL9 studies
- Birmingham, AL9 studies
- Dallas, TX8 studies
- Sacramento, CA8 studies
- Huntington Beach, CA8 studies
- Troy, MI8 studies
- Indianapolis, IN7 studies
Other studies in Charleston
- Depression19 studies
- Stroke18 studies
- Heart Failure18 studies
- Non-Small Cell Lung Cancer16 studies
- Post-Traumatic Stress Disorder16 studies
- Cardiovascular Disease15 studies
- Prostate Cancer15 studies
- Cancer (all types)14 studies
- Head and Neck Squamous Cell Carcinoma14 studies
- Parkinson's Disease13 studies
- Interstitial Lung Diseases13 studies
- Breast Cancer12 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.